Medication info

Ornithine Infusion Injection (L-Aspartate-L-Ornithine)

Prescription medication
Ingredient · strength
L-Ornithine-L-Aspartate›500mg / 1mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
A brown ampoule containing a colorless to light yellow transparent liquid
Packaging
10 mL/ampoule
Approval status
Active

MFDS item code 200500384 · Notified 2005.12.15

Summary

Main use
Treatment of hepatic encephalopathy in severe liver disease (including precoma and coma)
Who uses it
Adults
Adult dosage
* 500 mg/mL, 5 g/10 mL For hepatic encephalopathy (including precoma and coma), up to 40 g/day (8 ampules) of L-aspartic acid-L-ornithine may be mixed with a suitable infusion solution and administered by intravenous infusion. The dose may be adjusted as appropriate according to symptoms.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hepatic encephalopathy in severe liver disease (including precoma and coma)

  • Detoxification for severe liver disease
  • hepatic encephalopathy
  • pre-comatose state
  • coma
View approved original text

This medication is used for detoxification in severe liver disease, particularly in the pre-comatose and comatose state of hepatic encephalopathy. Hepatic encephalopathy is a condition where liver function is severely impaired, affecting brain function, and this medication helps treat it. Therefore, it plays an important role in improving the symptoms associated with serious liver disease.

Dosage and Administration

Adult dosage

* 500 mg/mL, 5 g/10 mL For hepatic encephalopathy (including precoma and coma), up to 40 g/day (8 ampules) of L-aspartic acid-L-ornithine may be mixed with a suitable infusion solution and administered by intravenous infusion. The dose may be adjusted as appropriate according to symptoms.

Precautions

This medication is in an ampoule form, so when opening the container, care should be taken as glass fragments may mix in. Particularly caution is needed when administering to children and the elderly. This medication should not be administered to patients with certain diseases. For example, it should not be used in patients with lactic acidosis, methanol poisoning, fructose-sorbitol intolerance, fructose-1,6-diphosphatase deficiency, and severe renal function impairment. Additionally, as it contains sulfite, it may cause allergic reactions or asthma attacks; hence, patients with asthma or those sensitive to sulfite should use it cautiously. During use, symptoms such as warmth at the back of the neck, nausea, or vomiting may occasionally occur. In cases of high dosage, blood and urine urea levels should be checked to monitor the patient's condition. If liver function is poor, the infusion rate should be adjusted to minimize discomfort or vomiting. It is important to slowly inject this medication intravenously. When stored, keep it out of reach of children, and do not transfer the medication from its original container to another container. This is to prevent misuse or deterioration of the medication's quality.

Side effects

  • Heat sensation in the posterior neck
  • nausea
  • abdominal discomfort
  • vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in an opaque container that does not allow light in. Additionally, it should be stored at room temperature between 1 degree and 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

A brown ampoule containing a colorless to light yellow transparent liquid

Package unit

10 mL/ampoule

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.